Evidence map›Paper›PMID 36551365›Full record

ArticleAntibiotics (Basel, Switzerland)2022

ABP-Finder: A Tool to Identify Antibacterial Peptides and the Gram-Staining Type of Targeted Bacteria.

Yasser B Ruiz-Blanco, Guillermin Agüero-Chapin, Sandra Romero-Molina, Agostinho Antunes, Lia-Raluca Olari, Barbara Spellerberg, Jan Münch, Elsa Sanchez-Garcia

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Yasser B Ruiz-BlancoComputational Biochemistry, Center of Medical Biotechnology, University of Duisburg-Essen, 45141 Essen, Germany.
Guillermin Agüero-ChapinCIIMAR-Centro Interdisciplinar de Investigação Marinha e Ambiental, Universidade do Porto, Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos, s/n, 4450-208 Porto, Portugal.ORCID 0000-0002-9908-2418
Sandra Romero-MolinaComputational Biochemistry, Center of Medical Biotechnology, University of Duisburg-Essen, 45141 Essen, Germany.
Agostinho AntunesCIIMAR-Centro Interdisciplinar de Investigação Marinha e Ambiental, Universidade do Porto, Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos, s/n, 4450-208 Porto, Portugal.ORCID 0000-0002-1328-1732
Lia-Raluca OlariInstitute of Molecular Virology, University Hospital Ulm, 89081 Ulm, Germany.ORCID 0000-0001-7793-4408
Barbara SpellerbergInstitute of Medical Microbiology and Hygiene, University Hospital Ulm, 89081 Ulm, Germany.ORCID 0000-0001-7552-8764
Jan MünchInstitute of Molecular Virology, University Hospital Ulm, 89081 Ulm, Germany.ORCID 0000-0001-7316-7141
Elsa Sanchez-GarciaComputational Biochemistry, Center of Medical Biotechnology, University of Duisburg-Essen, 45141 Essen, Germany.
University of Duisburg-Essen · DEUniversidade do Porto · PTUniversity Hospital Ulm · DEInstitute of Medical Microbiology and Hygiene · DE

Funding

Deutsche Forschungsgemeinschaft CRC 1279Deutsche Forschungsgemeinschaft CRC 1430Deutsche Forschungsgemeinschaft EXC 2033Deutsche Forschungsgemeinschaft Project-ID: 436586093Portuguese Foundation for Science and Technology (Fundação para a Ciência e a Tecnologia) UIDB/04423/2020 and UIDP/04423/2020
6 · The paper itself

Abstract

Multi-drug resistance in bacteria is a major health problem worldwide. To overcome this issue, new approaches allowing for the identification and development of antibacterial agents are urgently needed. Peptides, due to their binding specificity and low expected side effects, are promising candidates for a new generation of antibiotics. For over two decades, a large diversity of antimicrobial peptides (AMPs) has been discovered and annotated in public databases. The AMP family encompasses nearly 20 biological functions, thus representing a potentially valuable resource for data mining analyses. Nonetheless, despite the availability of machine learning-based approaches focused on AMPs, these tools lack evidence of successful application for AMPs' discovery, and many are not designed to predict a specific function for putative AMPs, such as antibacterial activity. Consequently, among the apparent variety of data mining methods to screen peptide sequences for antibacterial activity, only few tools can deal with such task consistently, although with limited precision and generally no information about the possible targets. Here, we addressed this gap by introducing a tool specifically designed to identify antibacterial peptides (ABPs) with an estimation of which type of bacteria is susceptible to the action of these peptides, according to their response to the Gram-staining assay. Our tool is freely available via a web server named ABP-Finder. This new method ranks within the top state-of-the-art ABP predictors, particularly in terms of precision. Importantly, we showed the successful application of ABP-Finder for the screening of a large peptide library from the human urine peptidome and the identification of an antibacterial peptide.

Indexed as

AMPs databaseantibacterial peptideGram staining-based targethuman peptidomemachine learningpeptide library screeningStarPep

Identifiers

PMID36551365
PMCPMC9774453
OpenAlexW4310215422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.